Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory T Lymphocyte Population in the Intestine (Intestinal Tregs)
- Target
- Intestinal Tregs
- Molecular classification
- Lymphocyte Population, T Cell Subset, Immunoregulatory Cells
01
Overview
Regulatory T lymphocytes (Tregs) are a specialized subset of CD4+ T lymphocytes that play a central role in maintaining immune tolerance and homeostasis within the intestinal environment. They suppress effector immune responses against self-antigens, food antigens, and commensal bacteria, preventing autoimmunity or chronic inflammation. Intestinal Treg populations arise from thymus-derived (tTregs) and peripherally induced (pTregs) sources, with pTregs differentiating in the gut due to factors like retinoic acid, TGF-β, and signals from commensal microbiota. Defective function or numbers of intestinal Tregs contribute to inflammatory bowel diseases, making them a therapeutic target for autoimmune/inflammatory disorders affecting the gastrointestinal tract.
- Other names
- Intestinal Regulatory T CellsGut TregsFoxp3+ Tregs in the IntestineCD4+ Regulatory T Cells in the Intestine
02
Mechanism of action
N/A
03
Biological functions
Immune suppressionImmune tolerance inductionRegulation of intestinal inflammationMaintenance of intestinal homeostasisTissue repair in the gutBarrier maintenance
04
Disease associations
Inflammatory Bowel Diseases (IBD)Crohn's DiseaseUlcerative ColitisAutoimmune disorders affecting the gastrointestinal tract
05
Safety considerations
Potential for systemic immune suppressionRisk of infectionOff-target effects on other immune cells
06
Biomarkers
FOXP3 expressionCD25 expressionIL-10 productionTGF-β productionRORγt expression
Beyond the preview
Go deeper on Regulatory T Lymphocyte Population in the Intestine (Intestinal Tregs).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regulatory T Lymphocyte Population in the Intestine (Intestinal Tregs).